Publication | Open Access

PPARγ agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway

InflammationMolecular PharmacologyAnti-inflammatoryMolecular PhysiologyMedicineVascular PharmacologyPhysiologyImmunologyChronic InflammationVascular BiologyIi-induced Vascular InflammationTlr4-dependent Signaling PathwayPharmacologyInflammatory DiseaseCell SignalingPparγ AgonistMolecular Signaling